Maybe but it all feels very loosey-goosey to me. LP should really button things up. The contract with UCLA is ancient unless I missed an updated version? Plus there’s the issue of what’s protected with treating other kinds of disease? It’s a shame she never provided shareholders with a patent presentation. 🤷♀️